Institutional investors purchased a net $7.7 million shares of ALIM during the quarter ended March 2014, and now own 44.75% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LIVINGSTON GROUP ASSET MANAGEMEN... Sold 3.0 Thousand shares of Alimera Sciences Inc